RBB-100

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRBB-100
Drug Alias Nameengineered annexin A5 immunotherapeutic (Rubicon Biotechnology)RBB-100
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAnnexin A5 modulators
TargetsAnnexin A5
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMosaMedix BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRubicon Biotechnology Llc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A